Prostatic Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)

Clinical trial NCT04563221 · WITHDRAWN

Trial details

NCT number: NCT04563221
Sponsor: Andrew Picel
Status: WITHDRAWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms

Start date: 2022-05-01
Primary completion: 2023-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.